{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-224944","form_type":"8-K","ticker":"MIRM","cik":"0001759425","company_name":"Mirum Pharmaceuticals, Inc.","filed_at":"2023-08-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.136027+00:00","generated_at":"2026-06-11T02:02:36.548481+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Mirum amends severance plan; expands CEO/NEO change-in-control benefits","bullets":["CEO Peetz: 12mo base salary + 12mo equity vesting (non-CIC); 24mo salary + 200% bonus + full vesting (CIC).","NEOs Longpre, Radovich, Vig: 9mo salary + 12mo vesting (non-CIC); 18mo salary + 150% bonus + full vesting (CIC).","Plan amendment removes automatic sunset provision; administrative changes made.","New participation agreements with each NEO reflect modified benefits."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-224944","json":"https://secwatch.observer/filing/0001193125-23-224944.json","markdown":"https://secwatch.observer/filing/0001193125-23-224944.md","text":"https://secwatch.observer/filing/0001193125-23-224944.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1759425/000119312523224944/0001193125-23-224944-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1759425/000119312523224944/d549647d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T02:02:36.548481+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}